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Background: Respiratory symptoms are related to anxiety and depression in several
cross-sectional studies but the association has not been explored in longitudinal
studies.
Study objectives: To prospectively study the change in dyspnea in relation to
symptoms of anxiety and depression over a 9-year time period.
Methods: The study comprised of 515 adults from a population sample who had
participated in the European Commission Respiratory Health Survey (ECRHS) I in
1991–1992 and in the ECRHS II in 1999–2000. The questionnaire included a modified
British Medical Research Council Scale for dyspnea grading and the Hospital Anxiety
and Depression scale questionnaire.
Results: The prevalence of dyspnea was 10.7% in the first and 12.6% in the second
survey. Symptoms of depression was an independent determinants for dyspnea in
both surveys (OR (95% CI) 3.72 (1.51–9.17) and 3.40 (1.49–7.80), respectively). In
subjects that did not have dyspnea at the first survey onset of symptoms of anxiety
(OR 3.53 (1.03–12.1)) and depression (OR 12.2 (3.97–37.5)) were significantly
related to having dyspnea at the second survey, whereas onset of dyspnea was not
significantly associated with developing symptoms of anxiety or depression when
each disorder was entered separately.
Conclusion: Our data indicates that there is a causal relationship between
development of symptoms of anxiety and depression and dyspnea. Psychological
status is therefore an important factor to consider both when evaluating the resultsElsevier Ltd. All rights reserved.
114115; fax: +46 186110228.
dsci.uu.se (C. Janson).
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that have dyspnea.
& 2006 Elsevier Ltd. All rights reserved.ECRHS I Stage 1
n=31451990Introduction
Dyspnea is a clinical term used to describe the
subjective feeling of impaired breathing. The term
comprises a wide range of respiratory symptoms
such as shortness of breath, increased respiratory
rate or altered depth in respiration.1 Psychiatric co-
morbidity is common in patients with asthma and
chronic obstructive pulmonary disease (COPD)2–5
and an association between anxiety and depression
and respiratory symptoms has been found in cross-
sectional population studies.6–8
The cause and effect relationship between
psychological factors and dyspnea is, however,
unclear. There are indications that dyspnea may
induce psychiatric disorders9 while other studies
indicate that psychological illnesses intensify the
subjective sensation of dyspnea.10,11 The European
Community Health Survey II (ECRHS II) is a long-
itudinal population study where adults aged 20–44
years were followed for 9 years.12 In one of the
centres anxiety and depression was assessed at
base-line6 and the follow-up. This gave us a unique
opportunity to study how changes in psychological
status affected development of dyspnea over a
9-year follow-up period. The primary aim of the
present analysis was therefore to explore the
association between change in psychological status
and dyspnea.Stage 2 
“random” 
n=623 
ECRHS II 
“random” 
n=517
Stage 2 
“symptomatic” 
n=201
ECRHS II 
“symptomatic” 
n=162
1999-2000
Dyspnea and 
HAD evaluation 
n=515 
1990-1992
Figure 1 Study design.Population and methods
A postal questionnaire was sent to a randomly
selected group of 3600 inhabitants of the munici-
pality of Uppsala, Sweden in the age group 20–44
years within the European Commission Respiratory
Health Survey (ECRHS) conducted in 1990–1992.13
The questionnaire consisted of 17 questions relat-
ing to respiratory symptoms, medication, and
smoking. The response rate was 87% (n ¼ 3145). A
random sample of 800 of the 3145 subjects that
answered the questionnaire and 216 subjects
that reported asthmatic symptoms or current
asthma medication and were not included in the
random sample were invited to a clinical examina-
tion (Fig. 1). The examination in the ECRHS
consisted of a structured interview with questions
on respiratory symptoms, current medication andprevious exposure to specific environmental factors
and spirometry. The follow-up study, the ECRHS II12
took place in 1999–2000 and included 679 subjects
(response rate 82.4%). The protocol was in general
identical to the one used in the previous survey
(Fig. 1).
Estimation of dyspnea
Dyspnea was measured using a modification of the
British Medical Research Council Scale (the MRC
scale) which has been used in epidemiologic surveys
since 1960 and provide a sensitive and objective
tool in a standardised setting of dyspnea.11,14,15
The following categorisation was used: ‘No dys-
pnea’ gave nil points, ‘feeling short of breath when
being in a hurry walking on level ground or up a
smaller hill’ 1 point, ‘feeling short of breath when
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ground’ two points and ‘having to stop to catch
once breath when walking at desired speed on level
ground?’ three points. The original MRC scale
includes two more questions that were not included
in the ECRHS protocol, given that our population
was relatively young and healthy.
Evaluation of psychological status
The Hospital Anxiety and Depression Scale (the HAD
scale) was originally developed to detect psycho-
logical illness in physically disabled patients ad-
mitted in medical clinics.16 Comparisons with
similar scales have shown that the HAD scale
is a valid tool for personal screening and for use
in outpatient clinics.17,18 The HAD scale consists
of 14 items with 7 questions of anxiety and 7
questions of depression rated on a four-point
scale from 0 to 3. The item scores represent the
degree of distress from none, a little, a lot, to
unbearably. The items are summed resulting in a
maximum of 21 points. Various cut-offs have been
applied by investigators. Using psychiatric diagnosis
as a gold standard HAD depression ratings of scores
of eight and higher indicate the presence of
suggested or probable anxiety and depression,
respectively.16,17
Asthma
Current asthma was defined as answering yes to the
questions: ‘Have you ever had asthma?’ and ‘Have
you had an attack of asthma in the last 12 months?’
Smoking
Information on smoking history was collected by
administered questionnaire at each occasion.
Those who answered ‘yes’ to the lead question
(‘Have you ever smoked for as long as one year?’)
were asked ‘Do you smoke now, as of one month
ago’. Based on the answer of these questions the
subjects were categorised as non-, ex- or current
smokers. Four categories were subsequently
formed when analysing change in smoking history;
non-smokers, smoking debutants, ex-smokers and
persistent smokers.
Spirometry
Forced expiratory volume in 1 s (FEV1) was mea-
sured using a dry rolling seal spirometer system
(Sensor Medics 2130, Sensor Medics, Anaheim, CA,
USA). Up to five technically acceptable blows weredetermined. The results were expressed as per cent
of predicted using the European Community for
Coal and Steel reference values.19
Body mass index
Body mass index (BMI) was calculated as weight
(kg)/[height (m)]2.
The study was approved by the Ethical Commit-
tee of the Medical Faculty at the University of
Uppsala. All subjects gave their permission for
utilisation of personal data for this study.
Statistical methods
The statistical analysis was performed using Stat-
View 5.0 (SAS Institute Inc., Cary, NC, USA) and
Stata 8.0 (Stata Corporation, College Station,
Texas). The w2-test and the unpaired t-test was
used in the univariate comparisons between parti-
cipates and non-participants and subjects with and
without dyspnea, respectively. McNemars-test was
used when comparing the prevalence of dyspnea
and psychological disorders between the two
surveys. Risk factors for dyspnea and anxiety and/
or depression were analysed using multiple logistic
regression analysis. A P-value o0.05 was consid-
ered significant. Analyses of interaction were used
to study the possibility of a gender difference in the
association between dyspnea and psychological
status.Results
Characteristics of the population
The present analysis included subjects that had
answered the dyspnea questions and completed the
HAD questionnaire in both surveys (n ¼ 542).
Twenty-seven subjects reported having disabled
capability to walk due to non-respiratory causes
and were therefore excluded. Of the 515 subjects
analysed, 397 were from the random population
and 118 from the ‘‘symptomatic sample’’ (Fig. 1).
There were 258 men and 257 women, mean age was
33 years (range 20–45 years) in the first survey and
41 years (28–54 years) in the follow-up. The mean
follow-up time was 8.6 (range 7.8–9.5) years.
Prevalence of dyspnea, anxiety and
depression
There was no significant difference in the pre-
valence of dyspnea between the two surveys
ARTICLE IN PRESS
Å. Neuman et al.1846(Table 1). The prevalence of symptoms of anxiety
decreased significantly while there was no signifi-
cant change in the prevalence of suggested or
probable depression (Table 1).Table 1 Prevalence (%) of dyspnea and symptoms of anx
absolute difference and 95% confidence interval (CI) betw
1991–1992
Dyspnea grades 1–3 10.7
Dyspnea grades 2–3 2.8
Dyspnea grade 3 0.8
Anxiety 26.4
Depression 7.4
Anxiety and/or depression 28.5
Table 2 Determinants of dyspnea at the first and secon
Risk factor N
Women 257
Age 1991–1992 (10-year increase)
FEV1 1991–1992 (10% increase)
BMI 1991–1992 (5 units increase)
Current asthma
1991–1992 71
1999–2000 54
Smoking habits 1991–1992
Non-smoker 267
Ex-smoker 124
Smoker 124
Smoking habits 1991–2000
Persistent non-smoker 376
Started to smoke 10
Stopped smoking 56
Persistent smoker 68
Psychological status 1991–1992y
No disorder 368
Anxiety 136
Depression 38
Anxiety and/or depression 147
Psychological status 1999–2000y
No disorder 409
Anxiety 95
Depression 44
Anxiety and/or depression 106
Adjusted for sample (random or symptomatic) and all the var
yEach type of psychological symptom was entered separately.Cross-sectional analyses
Female gender, depression and having a low FEV1
significantly increased the risk for dyspnea in bothiety and depression in 1991–1992 and 1999–2000 and
een the two surveys (n ¼ 515).
1999–2000 Difference % (95% CI)
12.6 1.9 (0.9, 4.8)
3.5 0.8 (1.0, 2.6)
0.6 0.2 (1.2, 0.8)
18.5 7.9 (11.5, 3.8)
8.6 1.2 (1.5, 4.2)
20.6 8.0 (12.1, 3.9)
d survey.
Dyspnea
1991–1992 1999–2000
OR 95% CI OR 95% CI
3.82 1.86–7.81 2.99 1.59–5.63
1.65 1.04–2.63 1.67 1.10–2.54
0.74 0.57–0.95 0.77 0.61–0.96
1.85 1.19–2.88 1.51 0.98–2.31
2.99 1.31–6.47
1.88 0.86–4.13
1
1.11 0.49–2.50
0.82 0.38–1.81
1
3.24 0.55–19.0
1.33 0.55–3.22
2.13 1.03–4.39
1
2.76 1.41–5.42
3.72 1.51–9.17
2.38 1.22–4.65
1
1.90 0.96–3.74
3.40 1.49–7.80
1.80 0.93–3.50
iables in the table.
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related to dyspnea in the first survey and being a
persistent smoker during the study period signifi-
cantly increased the risk of dyspnea at follow-up
(Table 2).Longitudinal analyses
Onset of symptoms of anxiety and depression was
significantly related to having dyspnea in the ECRHS
II among subjects that did not have dyspnea in
ECRHS I (Table 3). No significant association was
found between symptoms of anxiety and or
depression at baseline and onset of dyspnea
(adjusted OR (95% CI) 1.38 (0.65–2.93).
Onset of dyspnea was not significantly associated
with symptoms of anxiety or depression in the
ECRHS II among subjects without anxiety and
depression symptoms in the ECRHS I (Table 4). A
significant association between onset of dyspnea
and psychological status was, however, found when
anxiety and depression were combined.
There was no significant difference between men
and women in the association between psychologi-
cal status and dyspnea, when this was analysed by
interaction analyses.Non-responders
Subjects that did not participated in the present
investigation were more often smokers (35.6% vs.
24.1%, P ¼ 0:003) and had a higher prevalence of
anxiety (39.6% vs. 26.4%) and dyspnea (19.3% vs.
10.7%) (Po0:001) in the ECRHS I than the partici-
pants. No significant differences were found re-
garding age, sex, asthma or depression between
the participants and non-participants.Table 3 Dyspnea at follow-up in subjects without dysp
status (n ¼ 441).
Onset of anxiety
Onset of depression
Onset of anxiety or depression
Persistent anxiety
Persistent anxiety or depression
Each type of psychological symptom was entered separately.
yAdjusted for sample (random or symptomatic), age, gender, ch
in smoking status.
Too few subjects to analyse the relationship between persisteDiscussion
The main findings of this study are that symptoms
related to anxiety and especially depression are
important determinants for the development of
dyspnea, while there was less evidences that
dyspnea induces psychological symptoms.
A significant relation between respiratory symp-
toms and anxiety and depression has been found in
many previous cross-sectional studies,6–8,11,20 but
to our best knowledge the associations between
psychological status and dyspnea have not pre-
viously been investigated in a longitudinal popula-
tion study. In the present study, the risk of
developing dyspnea was increased in subjects that
developed symptoms of anxiety and depression
during the follow-up. No significant association
between persistent psychological symptoms and
onset of dyspnea was found.
There are two possible ways to interpret our
results. The first is that the increased dyspnea is
the cause of psychological symptoms which is in
accordance with what was found in a study of
patients with severe COPD. In that study, van
Manen et al. found that the risk for depression was
2.5 times greater compared to controls.9 Likewise,
Goodwin et al. found that asthma was associated
with a significantly increased likelihood of having
anxiety disorder, panic disorder, social phobia,
generalised anxiety disorder, and bipolar disor-
der.21,22 The second interpretation is that psycho-
logical symptoms is the causes of dyspnea by
intensifying the subjective sensation of dyspnea.11
This is in accordance with the results of Tiller and
co-workers, who found that correlations between
estimates of resistive loads and peak inspiratory
mouth pressure were significantly less for the
anxious patients than for normal subjects.10nea at baseline in relation to change in psychological
Onset of dyspnea
N ORy 95% CI
34 3.53 1.03–12.1
29 12.2 3.97–37.5
39 4.35 1.38–13.7
51 2.30 0.73–7.28
58 2.08 0.66–6.53
ange in asthma status, baseline FEV1, baseline BMI and change
nt depression and onset of dyspnea.
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Table 4 Psychological disorders at follow up in subjects without disorders at baseline in relation to change in
dyspnea status (n ¼ 354).
N Psychological status
Anxiety Depression Anxiety and/or
depression
ORy 95% CI ORy 95% CI ORy 95% CI
No dyspnea 348 1 1 1
Onset of dyspnea 25 3.01 0.81–11.1 5.00 0.73–34.4 3.93 1.12–13.8
Persistent dyspnea 16 0.38 0.03–4.45 — — 0.42 0.04–4.41
Each type of psychological symptom was entered separately.
yAdjusted for sample (random or symptomatic), age, gender, change in asthma status, baseline FEV1, baseline BMI and change
in smoking status.
Å. Neuman et al.1848The results of the present study gives more
support for psychological symptoms being the cause
of dyspnea than the opposite. Onset of suggested or
probable anxiety and depression increased the risk
of developing dyspnea among subjects that did not
have dyspnea in the first survey. On the other hand
the onset of dyspnea was not significantly asso-
ciated with developing symptoms of anxiety or
depression when each condition was analysed
separately. There are two known conditions in
which emotional breathing patterns can cause
dyspnea. The former is dyspnea in patients with
panic disorder and hyperventilation.22–24 The latter
occurs when emotional breathing turns into ex-
cessive inspiration. This will lead to a hyperinfla-
tion of the airways that evokes a sense of
dyspnea.25 There was, however, no significant
relationship between psychological status at base-
line and onset of dyspnea. It is therefore not
possible to draw a firm conclusion on the cause
effect relationship between psychological status
and dyspnea.
No significant gender difference was found in the
association between psychological status and dys-
pnea but in accordance with other studies the
prevalence of dyspnea was higher among women
than men.26,27 There are several possible explana-
tions for these results. There is for instance the
difference in anatomy, with women having smaller
lungs than men. Hormonal differences may also be
part of the explanation, as progesterone is a
recognised respiratory stimulant. The age group
mainly includes females in their fertile period who
probably are more susceptible to dyspnea due to
the cyclical hormonal variations.27,28
A higher BMI was related to increased dyspnea. In
some studies, obese subjects report more asthma-
like symptoms and a higher usage of asthma
medication but have the same level of airwayhyperresponsiveness and airflow obstruction as
subjects with normal body weight.29,30 Another
study has, however, found a significant relationship
between a higher BMI and bronchial hyperrespon-
siveness.31 Obesity has been shown to adversely
affect respiratory mechanisms and gas exchange,
decrease respiratory muscle function and lung
volumes, and increase the effort of breathing.28,29
As expected from previous studies, ageing, smoking
and low lung function was also found to be
determinants of dyspnea.26
Some methodological issues are worth discussing.
The response rate was relatively high but we did
find that the non-participants differed from the
participants in several aspects. The non-partici-
pants were more often smokers and had a higher
prevalence of dyspnea and anxiety in the ECRHS I
than the participants. This may have reduced the
possibility of finding a significant association be-
tween persistent anxiety symptoms and dyspnea. It
is also possible that the results may have been
affected by other exposures not controlled for in
the present study such as marital and socioeco-
nomic status. The MRC scale has been widely used
in epidemiologic surveys and has been shown to be
a sensitive and valid tool in a standardised
setting.15 The scale has been modified in our study
since the last two steps of the scales are not
included. The prevalence of dyspnea grade 3 was
low. Omitting the two last steps (‘having to stop for
breath after walking 100 yards’ and ‘being too
breathless to leave the house’) has therefore
probably not affected our results. The HAD scale
has proven to correspond well with established
scales currently used in the field of psychiatry, such
as the American Psychiatric Association’s Diagnostic
and statistical Manual (DSM-3), Beck Depression
Inventory (BDI) and Spielberger’s State Trait Anxi-
ety inventory (STAI).17,18
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ship between development of psychological symp-
toms and dyspnea. Psychological status is therefore
an important factor to consider both when evalu-
ating the results of epidemiological respiratory
studies and in clinical settings when treating
patients that have dyspnea.Acknowledgement
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